Standards and impact of hematopathology in myelodysplastic syndromes (MDS).

Oncotarget

Volumn 1, Issue 7, 2010, Pages 483-496

  Valent, Peter ^a   Orazi, Attilio ^b   Büsche, Guntram ^b   Schmitt Gräff, Annette ^b   George, Tracy I ^b   Sotlar, Karl ^b   Streubel, Berthold ^b   Beham Schmid, Christine ^b   Cerny Reiterer, Sabine ^b   Krieger, Otto ^b   van de Loosdrecht, Arjan ^b   Kern, Wolfgang ^b   Ogata, Kiyoyuki ^b   Wimazal, Friedrich ^b   Várkonyi, Judit ^b   Sperr, Wolfgang R ^b   Werner, Martin ^b   Kreipe, Hans ^b   Horny, Hans Peter ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BLOOD; BLOOD EXAMINATION; BONE MARROW CELL; DIAGNOSIS, MEASUREMENT AND ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MYELODYSPLASTIC SYNDROME; PATHOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; STANDARD;

BONE MARROW CELLS; GUIDELINES AS TOPIC; HEMATOLOGIC TESTS; HUMANS; IMMUNOHISTOCHEMISTRY; LABORATORY TECHNIQUES AND PROCEDURES; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; REFERENCE STANDARDS; TUMOR MARKERS, BIOLOGICAL;

EID: 79957991763     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.185     Document Type: Review

References (0)